Szeman Ruby Chan
Impact in
- Oncology top 10%
- Viral-associated cancers and disorders
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immune cells in cancer
Papers in
- Co-authors
- Bala Chandran (3 shared papers)Clark Bloomer (2 shared papers)Robert Schreiber (7 shared papers)Amy M. Fowler (4 shared papers)Alexis K. Smith (1 shared paper)Natasha M. Girgis (1 shared paper)Michael M. Quigley (1 shared paper)Douglas H. Yamada (2 shared papers)
- Journals
- Journal of Nuclear Medicine (2 papers)Virology (2 papers)Clinical Cancer Research (1 paper)Cancers (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Szeman Ruby Chan
16 papers receiving 801 citations
Peers
Comparison fields: 5 of 52
- Oncology 374
- Immunology 207
- Cancer Research 87
- Radiology, Nuclear Medicine and Imaging 95
- Genetics 103
Countries citing papers authored by Szeman Ruby Chan
This map shows the geographic impact of Szeman Ruby Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szeman Ruby Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szeman Ruby Chan more than expected).
Fields of papers citing papers by Szeman Ruby Chan
This network shows the impact of papers produced by Szeman Ruby Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szeman Ruby Chan. The network helps show where Szeman Ruby Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Szeman Ruby Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 153 | |
| 2 | 2017 | 152 | |
| 3 | 1998 | 92 | |
| 4 | 1998 | 78 | |
| 5 | 2012 | 61 | |
| 6 | 2013 | 57 | |
| 7 | 2000 | 51 | |
| 8 | 2019 | 40 | |
| 9 | 2013 | 39 | |
| 10 | 2014 | 32 | |
| 11 | 2016 | 22 | |
| 12 | 2016 | 8 | |
| 13 | 2015 | 7 | |
| 14 | 2017 | 7 | |
| 15 | 2022 | 6 | |
| 16 | STAT1-deficient mice spontaneously develop estrogen receptor alpha-positive luminal mammary carcinomas | 2012 | 4 |
About Szeman Ruby Chan
Szeman Ruby Chan is a scholar working on Genetics, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Cancer Research, having authored 16 papers that have together received 809 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (7 papers), Medical Imaging Techniques and Applications (3 papers), Viral-associated cancers and disorders (3 papers), Breast Cancer Treatment Studies (2 papers), Immunotherapy and Immune Responses (2 papers), Radiopharmaceutical Chemistry and Applications (1 paper), Bone health and treatments (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Oncology (374 citations), Immunology (207 citations), Cancer Research (87 citations), Radiology, Nuclear Medicine and Imaging (95 citations) and Genetics (103 citations). Szeman Ruby Chan has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Bala Chandran, Clark Bloomer, Robert Schreiber, Amy M. Fowler, Alexis K. Smith, Natasha M. Girgis, Michael M. Quigley, Douglas H. Yamada, Iqbal S. Grewal and Raluca I. Verona. Their work appears in journals such as Journal of Nuclear Medicine, Virology, Clinical Cancer Research, Cancers and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.